Impaired bone formation and osteoporosis in postmenopausal elderly onset rheumatoid arthritis patients

被引:12
作者
Gheita, T. [1 ]
Fawzy, S. [1 ]
Rizk, A. [2 ]
Hussein, H. [3 ]
机构
[1] Cairo Univ, Fac Med, Dept Rheumatol, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Orthoped Surg, Cairo, Egypt
[3] Cairo Univ, Fac Med, Dept Chem Pathol, Cairo, Egypt
关键词
Rheumatoid arthritis; Postmenopausal osteoporosis; Impaired bone formation; Markers of bone turnover; Bone mineral density;
D O I
10.1016/j.ejr.2011.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Bone metabolism may be uncoupled in postmenopausal rheumatoid arthritis (RA). Osteoporotic fracture in RA is highest for the hip especially in elderly women. Aim of the work: To detect the bone mineral density (BMD) and markers of bone turnover in postmenopausal RA patients and study the influence of age at disease onset. Correlation with clinical and laboratory manifestations and disease activity were considered. Patients and methods: Sixty postmenopausal RA patients were recruited into two groups, group I: 30 elderly onset (EORA) and group II: 30 young onset (YORA) patients. Thirty age and sex matched healthy subjects served as control. Full history taking, clinical examination, relevant investigations including calcium, phosphorus, total alkaline phosphatase (ALP), bone specific alkaline phosphatase (BALP), osteocalcin (OC), and N-terminal cross-linked telopeptides of type I collagen (NTX) were measured and BMD assessed by DEXA in all patients and control. Disease activity score in 28 joints (DAS-28) was calculated. Results: The NTX was remarkably increased and the BMD decreased in RA patients. Osteocalcin in RA was 3.87 +/- 1.15 ng/ml being obviously lower in EORA patients compared to YORA and control. In EORA, a significant correlation was present between the ALP and OC (r 0.41, p 0.025) and the NTX and BALP (r 0.46, p 0.011) and a negative correlation between the hip BMD and DAS-28 (r -0.43, p 0.019). Conclusion: Impaired bone formation and uncoupling of bone turnover are more evident in postmenopausal EORA patients which form a risk predictor of fracture hip in this subgroup of patients. (C) 2011 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 46 条
  • [1] 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
    Aletaha, Daniel
    Neogi, Tuhina
    Silman, Alan J.
    Funovits, Julia
    Felson, David T.
    Bingham, Clifton O., III
    Birnbaum, Neal S.
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Cohen, Marc D.
    Combe, Bernard
    Costenbader, Karen H.
    Dougados, Maxime
    Emery, Paul
    Ferraccioli, Gianfranco
    Hazes, Johanna M. W.
    Hobbs, Kathryn
    Huizinga, Tom W. J.
    Kavanaugh, Arthur
    Kay, Jonathan
    Kvien, Tore K.
    Laing, Timothy
    Mease, Philip
    Menard, Henri A.
    Moreland, Larry W.
    Naden, Raymond L.
    Pincus, Theodore
    Smolen, Josef S.
    Stanislawska-Biernat, Ewa
    Symmons, Deborah
    Tak, Paul P.
    Upchurch, Katherine S.
    Vencovsky, Jiri
    Wolfe, Frederick
    Hawker, Gillian
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2569 - 2581
  • [2] [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1
  • [3] Bajocchi G, 2000, CLIN EXP RHEUMATOL, V18, pS49
  • [4] Monitoring osteoporosis therapy: Bone mineral density, bone turnover markers, or both?
    Bonnick, SL
    Shulman, L
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) : 25S - 31S
  • [5] Bone turnover markers in the management of postmenopausal osteoporosis
    Brown, Jacques P.
    Albert, Caroline
    Nassar, Bassam A.
    Adachi, Jonathan D.
    Cole, David
    Davison, K. Shawn
    Dooley, Kent C.
    Don-Wauchope, Andrew
    Douville, Pierre
    Hanley, David A.
    Jamal, Sophie A.
    Josse, Robert
    Kaiser, Stephanie
    Krahn, John
    Krause, Richard
    Kremer, Richard
    Lepage, Raymond
    Letendre, Elaine
    Morin, Suzanne
    Ooi, Daylily S.
    Papaioaonnou, Alexandra
    Ste-Marie, Louis-Georges
    [J]. CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 929 - 942
  • [6] The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica
    Ceccato, F.
    Roverano, S.
    Barrionuevo, A.
    Rillo, O.
    Paira, S.
    [J]. CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 854 - 857
  • [7] OSTEOPOROSIS IN RHEUMATOID-ARTHRITIS - EFFECT OF DISEASE-ACTIVITY
    CELIKER, R
    GOKCEKUTSAL, Y
    CINDAS, A
    ARIYUREK, M
    RENDA, N
    KORAY, Z
    BASGOZE, O
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (04) : 429 - 433
  • [8] Proinflammatory Cytokine Profiles of Patients with Elderly-Onset Rheumatoid Arthritis: A Comparison with Younger-Onset Disease
    Chen, Der-Yuan
    Hsieh, Tsu-Yi
    Chen, Yi-Ming
    Hsieh, Chia-Wie
    Lan, Joung-Liang
    Lin, Fang-Ju
    [J]. GERONTOLOGY, 2009, 55 (03) : 250 - 258
  • [9] CLEMENS JD, 1997, CLIN CHEM, V7, P1251
  • [10] Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men
    Fall, PM
    Kennedy, D
    Smith, JA
    Seibel, MJ
    Raisz, LG
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (06) : 481 - 485